CWM
HUMA icon

CIBC World Markets’s Humacyte HUMA Stock Holding History

CIBC World Markets’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.86K Buy
+10,265
New +$14.5K ﹤0.01% 1233
2025
Q2 		$32.3K Sell
15,443
-4,630
-23% -$8.89K ﹤0.01% 1506
2025
Q1 		$34.2K Buy
+20,073
New +$75.4K ﹤0.01% 1760

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Markets's HUMA Position: Q4 2025 in Review

CIBC World Markets opened a new position in Humacyte (HUMA) in Q4 2025: 10,265 shares worth $9.86K. The stake represents ﹤0.01% of the portfolio and ranks #1233 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in HUMA as recently as Q2 2025.

CIBC World Markets first reported a position in HUMA in Q1 2025 and has held it in 3 quarters since. The position peaked at $34.2K in Q1 2025. 147 funds tracked by Wall St. Rank hold HUMA as of Q4 2025.

  • CIBC World Markets held 10,265 shares of Humacyte worth $9.86K as of Q4 2025.
  • Humacyte was a new CIBC World Markets position in Q4 2025.
  • Humacyte made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1233 holding.
  • CIBC World Markets first reported a position in Humacyte in Q1 2025 and has held it in 3 quarters since.
  • CIBC World Markets's Humacyte position peaked at $34.2K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Humacyte as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.